Stock To Watch: Impax Laboratories, Inc. (NASDAQ:IPXL)


The leading market experts have placed a mean price target of $34.86 on Impax Laboratories, Inc. (NASDAQ:IPXL) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.48 a share for the upcoming quarter and $1.77 for the current fiscal. Technical View The technical analysis of Impax Laboratories, Inc. plainly substantiates that the 50-day moving average of Impax Laboratories, Inc. is $30.48, and stock is hovering 0.94 or +3.09% distant from $30.48. It is noted that the 200-day MA is $33.08, and Impax Laboratories, Inc. stock is $-1.66 or -5.01% off from this point. Impax Laboratories, Inc. (NASDAQ:IPXL) 52-week high is $49.59 and the 52-week low is $27.62. This explains if the stock moves $-18.17, it will post a 52-week high. In event of $+13.76% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Impax Laboratories, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Impax Laboratories, Inc. (NASDAQ:IPXL) ratio came in at 66.01. The stock last ended the trading session at $31.42 and registered a market cap of $2.23B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Impax Laboratories, Inc. (NASDAQ:IPXL) PEG ratio is at 0.74.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)